Welcome to the Hope Bio Blog

As released through Business Wire, by Jan Shultis, Ph.D. SUGAR LAND, Texas--(BUSINESS WIRE)--Hope Biosciences’ adipose-derived mesenchymal stem cells are effective in improving joint function in patients actively suffering from Rheumatoid Arthritis (RA), finds a FDA-authorized Phase I/IIa pilot trial. Fifteen patients received a single intravenous infusion of 200 million adipose-derived mesenchymal stem cells cultured by Hope Biosciences, also known as “HB-adMSCs.” Follow-ups